Omlonti for Glaucoma Glaucoma prevalence increases with age. The FDA has approved Omlonti (omidenepag isopropyl ophthalmic solution) 0.002% eye drops to reduce elevated intraocular pressure (IOP) in patients with primary open-angle glaucoma or ocular hypertension. These eye drops reduce the amount of fluid in the eye, lowering intraocular pressure. Omlonti is a selective prostaglandin EP2 receptor agonist. It increases aqueous…
María RomeroApril 23, 2023


















